Online Media Kit
Welcome to IPM's Online Media Kit, home to quick links that connect journalists and others to our press statements, key multimedia resources for background information on microbicides and IPM's work, and media highlights. Also learn how to contact experts in the field.
Quick Links
- Press Releases & Statements
- Multimedia
- IPM: Pioneering HIV prevention options for women (Fact sheet)
- Microbicide Overview (Fact sheet)
- A Long-Acting Vaginal Ring (Fact sheet)
Featured Media Highlights
FEATURED STORY
March 06, 2018 | POZ
Vaginal Ring Appears to Cut Women's HIV Rate in Half in New Study
The open-label follow-up to a previous placebo-controlled study of an HIV-preventing ring is seeing high use among women. More »
FEATURED STORY
December 19, 2017 | BBC World Hacks
The Ring That Could Help Save Women's Lives (AUDIO)
A new form of protection being tested in Malawi could be a real game-changer. World Hacks meets the women pioneering this approach and taking control of their own protection. More »
FEATURED STORY
May 04, 2017 | Economist (UK)
How to protect women against both HIV and pregnancy
A newly-developed vaginal ring releases small doses of drugs over a three-month period More »
FEATURED STORY
February 26, 2016 | The New York Times editorial
Helping Women in Africa Avoid H.I.V.
Now, women in the developing world have new hope. The results of two major studies in Africa that were released Monday show that a new device could help protect women against H.I.V. More »
Media Highlights
March 13, 2018 | Initiative for MPTs blog
A long-acting multipurpose prevention ring to help protect against HIV and unintended pregnancy
IPM blogs about its dapivirine-contraceptive ring and how it could help address women's sexual and reproductive health needs. More »
March 13, 2018 | Contemporary OB/GYN
New data on vaginal ring support benefits for HIV prevention
Interim data from two studies of a dapivirine vaginal ring—DREAM and HOPE—lend further credence to the potential benefits of using the device for HIV prevention More »
March 10, 2018 | FirstWord Pharma
Dapivirine Vaginal Ring Is Reducing Risk of HIV Infection Among Women in Serodiscordant Relationships: Presented at CROI
The HOPE study launched in August of 2016 as an extension of the phase 3 ASPIRE clinical trial. More »
March 09, 2018 | Healio / Infectious Disease News
Open-label studies show high uptake of vaginal ring for HIV prevention
“The data support the development of the ring as a potentially important new prevention option for women, who continue to bear the brunt of the epidemic and still lack a range of options that they... More »
March 08, 2018 | Medscape
HIV Incidence Drops Below 2% in Vaginal Ring Follow-ups
Women who used a dapivirine vaginal ring for HIV prevention were infected at a rate of less than 2%, according to interim data from the concurrent HOPE and DREAM extension trials. More »